T16	Effect 114 293	growth deficiency, developmental delay, craniosynostosis, blepharophimosis, flat nasal bridge, abnormal ears, and distal limb defects including hypoplastic thumbs and oligodactyly
T17	Treatment 22 59	in utero exposure to cyclosposphamide
T18	Subject 105 112	patient
T19	Drug 43 59	cyclosposphamide
T15	Adverse_event 60 66	shared
E1	Adverse_event:T15